Development and validation of early-stage and progression prediction models for chronic kidney disease: a retrospective study
PeerJ · 16.03.2026 · 14 · e20931
DOI: 10.7717/peerj.20931 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PeerJ, online erschienen am 16.03.2026. Verfasst von Tongyuan Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Laboratory Medicine, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyan…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Nomograms. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Chronic kidney disease (CKD) poses a significant public health burden. This study aimed to evaluate the associations between clinical laboratory indices and CKD and to develop prediction and prognostic models for CKD risk assessment and disease progression. Design & Methods Between January 2008 and June 2018, we enrolled 500 healthy controls, 445 patients with early-stage CKD (G1–G2), and 527 patients with CKD G5 at the First Hospital of China Medical University. Logistic regression analyses were performed to identify independent predictors for the presence of CKD and progression to advanced disease, which were subsequently incorporated into visual nomograms. Model performance was evaluated using area under the receiver operating characteristic curves (AUC) and calibration plots. Clinical utility was assessed using decision curve analysis (DCA) and clinical impact curves (CIC).
Results
The early-stage CKD prediction nomogram achieved an AUC of 0.981 in the training set and 0.969 in the validation set. The progression nomogram demonstrated AUC values of 0.984 and 0.972 in the training and validation sets, respectively. DCA and CIC analyses further confirmed the clinical relevance and potential applicability of both models.
Conclusions
We developed and validated early-stage prediction and progression assessment for CKD, demonstrating high discriminative ability, good calibration, and significant clinical utility. These models may facilitate early detection and dynamic risk assessment in CKD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Clinical Research Center for Laboratory Medicine, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, China.
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, NHC Key Laboratory of AIDS Prevention and Treatment, National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medica…
Zitieren
APA
Wan, T., Chen, Q., Gao, Y., Luo, R., Li, N., & Feng, Y. (2026). Development and validation of early-stage and progression prediction models for chronic kidney disease: a retrospective study. PeerJ, 14, e20931. https://doi.org/10.7717/peerj.20931
Vancouver
Wan T, Chen Q, Gao Y, Luo R, Li N, Feng Y. Development and validation of early-stage and progression prediction models for chronic kidney disease: a retrospective study. PeerJ. 2026;14:e20931. doi:10.7717/peerj.20931
BibTeX
@article{Wan2026,
author = {Wan, Tongyuan and Chen, Qi and Gao, Yiming and Luo, Renli and Li, Nan and Feng, Yonghui},
title = {Development and validation of early-stage and progression prediction models for chronic kidney disease: a retrospective study},
journal = {PeerJ},
year = {2026},
volume = {14},
pages = {e20931},
doi = {10.7717/peerj.20931}
}
EUVIMED